Cardiology information systems have high market potential in Europe
Departmental cardiovascular information systems (CVIS) have emerged and combined with a cardiology PACS have become the leading software feature in modern cardiology departments, according to a new report from the San Jose, Calif.-based market research firm Frost & Sullivan.
The European CIS market is currently worth $26.9 million in 2006, and is estimated to reach $83.6 million in 2013, according to the report.
“The growing emphasis on routine screening for individuals 45 years of age and older is merely indicative of the shift in recent years in the medical community away from acute interventional care and towards preventative care,” said Konstantinos Nikolopoulos, an industry analyst at Frost & Sullivan. “As a result, cardiac screening is now starting at a much earlier age, as physicians seek to uncover potential cardiovascular issues before the onset of chronic cardiopulmonary disease. This new philosophy is likely to contribute to the heightened demand for CIS.”
The report commented that the demands for diagnostic and interventional cardiology procedures will rise proportionately with the aging of the population. An ageing and increasingly health-conscious population exercises strong pressure on the financial resources required to run the national healthcare systems, which, in turn, are under pressure to reduce their running costs. The CIS market in Europe will certainly benefit from such strong driving forces, Frost & Sullivan predicts.
Frost & Sullivan reported that while clients have different demands from a CIS product, integration with other hospital IT systems is emerging as a primary user requirement.
“From the hospital manager’s perspective, a key strategy would be to achieve integration so as to provide clinicians with all the data in order to give them the best possible view of their patient’s condition,” says Nikolopoulos. “CIS vendors should be able to provide such high levels of integration with other departmental or enterprise IT systems.”
The European CIS market is currently worth $26.9 million in 2006, and is estimated to reach $83.6 million in 2013, according to the report.
“The growing emphasis on routine screening for individuals 45 years of age and older is merely indicative of the shift in recent years in the medical community away from acute interventional care and towards preventative care,” said Konstantinos Nikolopoulos, an industry analyst at Frost & Sullivan. “As a result, cardiac screening is now starting at a much earlier age, as physicians seek to uncover potential cardiovascular issues before the onset of chronic cardiopulmonary disease. This new philosophy is likely to contribute to the heightened demand for CIS.”
The report commented that the demands for diagnostic and interventional cardiology procedures will rise proportionately with the aging of the population. An ageing and increasingly health-conscious population exercises strong pressure on the financial resources required to run the national healthcare systems, which, in turn, are under pressure to reduce their running costs. The CIS market in Europe will certainly benefit from such strong driving forces, Frost & Sullivan predicts.
Frost & Sullivan reported that while clients have different demands from a CIS product, integration with other hospital IT systems is emerging as a primary user requirement.
“From the hospital manager’s perspective, a key strategy would be to achieve integration so as to provide clinicians with all the data in order to give them the best possible view of their patient’s condition,” says Nikolopoulos. “CIS vendors should be able to provide such high levels of integration with other departmental or enterprise IT systems.”